Viking Therapeutics

San Diego, United States

Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders.

$632.5M raised

Feb 2024

Post-IPO Equity

Health Care Medical Therapeutics

Top Investors

Ligand Pharmaceuticals Aspire Capital Partners LLC

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Viking Therapeutics

How much funding has Viking Therapeutics raised?

Viking Therapeutics has raised $632.5M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in February 2024.

Who are Viking Therapeutics's investors?

Viking Therapeutics's investors include Ligand Pharmaceuticals, Aspire Capital Partners LLC.

Where is Viking Therapeutics headquartered?

Viking Therapeutics is headquartered in San Diego, United States.

What does Viking Therapeutics do?

Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders.

What stage is Viking Therapeutics at?

Viking Therapeutics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 28, 2024.

MLA

"Viking Therapeutics — Funding & Investors." VCBacked, February 28, 2024, https://www.vcbacked.co/company/viking-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2024). Viking Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/viking-therapeutics

Wikipedia (cite web)

{{cite web |title=Viking Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/viking-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 28, 2024.

Similar Companies in Health Care

Allterum Therapeutics